Global Sciatica Treatment Market
Global Sciatica Treatment Market

Sciatica Treatment Comprehensive Study by Type (L4 Nerve Root Sciatica, L5 Nerve Root Sciatica, S1 Nerve Root Sciatica, Others), Drugs (Anesthetics, Pain killers, Muscle relaxants, Antidepressants, Steroids, Others), Non-Drug Treatment (Physiotherapy, Acupuncture, Stimulation devices, Surgery, Others), Treatment (Surgical Treatment, Non-Surgical Treatment), End user (Hospitals, Clinics, Research & Academics, Others) Players and Region - Global Market Outlook to 2024

Sciatica Treatment Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025 | CAGR: 5.82%  

Mar 2019 Edition 223 Pages 187 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Sciatica is the name given to pain caused by irritation of the sciatic nerve, anything which irritates this nerve can cause mild to severe pain. Sciatica is usually caused by a compressed nerve in the lower spine.This nerve is the longest and widest nerve in the human body. It runs from the lower back, through the buttocks, and down the legs, ending just below the knee. People who suffer from acute or chronic back pain tend to be more susceptible to Sciatica. The Global Sciatica Treatment market is anticipated to grow at a rapid pace due to rising in safety and success of drug treatment, surge in Geriatrics cases, high growth rate of screening, increase in population, and excruciating pain. Sciatica is triggered by activities like heavy lifting and jerky movements. Over the Counter Medications such as Acetaminophen (Tylenol) and Non-steroidal Anti-Inflammatory Drugs like ibuprofen (Motrin) and Naproxen (Aleve) are being used for the Sciatica Treatment.

The market study is being classified by Type (L4 Nerve Root Sciatica, L5 Nerve Root Sciatica, S1 Nerve Root Sciatica and Others) and major geographies with country level break-up. According to AMA, the Global Sciatica Treatment market is expected to see growth rate of 5.82%

Endo Pharmaceuticals Inc. (United States), AstraZeneca (United Kingdom), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Johnson & Johnson Services, Inc.(United States), Omega Laser Systems Ltd.(Netherlands), Pfizer Inc. (United States) and Sanofi (France) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Neurotech (United Kingdom), Nidd Valley Medical Ltd.(United Kingdom), Omron Healthcare, Inc. (United States) and Sollis Therapeutics (United States).

The Sciatica Treatment market is highly fragmented with Key players focusing on engaging in strategic alliances and collaborations with other players to offer highly differentiated products to cater to the evolving end-user requirements. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Sciatica Treatment market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Sciatica Treatment market by Type, Application and Region.

On the basis of geography, the market of Sciatica Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Drugs, the sub-segment i.e. Anesthetics will boost the Sciatica Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Non-Drug Treatment, the sub-segment i.e. Physiotherapy will boost the Sciatica Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Treatment, the sub-segment i.e. Surgical Treatment will boost the Sciatica Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End user, the sub-segment i.e. Hospitals will boost the Sciatica Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Prevalence of Disease Like Sciatica among Patients
  • Increasing Geriatric Population in the Past Few Years
  • Extra Pressure on Spine Due to Other Health Conditions
  • Rising Awareness about Sciatica Treatment

Market Trend
  • Development of Injections to treat Sciatica i.e. Clonidine Micropellet Epidural Injections

Restraints
  • High Cost of Treatment
  • Complications in Sciatic Surgery such as Risk of Bleeding, Infections etc.

Opportunities
  • Development of Medications with Micropellet Technology

Challenges
  • Surgery for the Treatment appears Less Effective in Patients Suffering Chronic Sciatica.


In November 2018, Sollis Therapeutics announced RePRIEVE-CM , Phase 3 trial for a new option is being tested for the treatment i.e. is a micro-pellet based injection which is injected near the inflamed nerve in the spine.It contains a medicine called Clonidine thatís slowly released as the pellet dissolves over time.It reduces the transmission of pain signals from the nerve to the brain. Clonidine is blood pressure medicine thatís being tested for a new use to reduce Sciatic pain.


Key Target Audience
Sciatica Manufacturers & Suppliers, Research and Development (R&D) Companies, Hospitals and Clinics, Academic Institutes and Universities, Government & Regulatory Bodies and Health Care Facilities

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • L4 Nerve Root Sciatica
  • L5 Nerve Root Sciatica
  • S1 Nerve Root Sciatica
  • Others
By Drugs
  • Anesthetics
  • Pain killers
  • Muscle relaxants
  • Antidepressants
  • Steroids
  • Others

By Non-Drug Treatment
  • Physiotherapy
  • Acupuncture
  • Stimulation devices
  • Surgery
  • Others

By Treatment
  • Surgical Treatment
  • Non-Surgical Treatment

By End user
  • Hospitals
  • Clinics
  • Research & Academics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Disease Like Sciatica among Patients
      • 3.2.2. Increasing Geriatric Population in the Past Few Years
      • 3.2.3. Extra Pressure on Spine Due to Other Health Conditions
      • 3.2.4. Rising Awareness about Sciatica Treatment
    • 3.3. Market Challenges
      • 3.3.1. Surgery for the Treatment appears Less Effective in Patients Suffering Chronic Sciatica.
    • 3.4. Market Trends
      • 3.4.1. Development of Injections to treat Sciatica i.e. Clonidine Micropellet Epidural Injections
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Sciatica Treatment, by Type, Drugs, Non-Drug Treatment, Treatment, End user and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Sciatica Treatment (Value)
      • 5.2.1. Global Sciatica Treatment by: Type (Value)
        • 5.2.1.1. L4 Nerve Root Sciatica
        • 5.2.1.2. L5 Nerve Root Sciatica
        • 5.2.1.3. S1 Nerve Root Sciatica
        • 5.2.1.4. Others
      • 5.2.2. Global Sciatica Treatment by: Drugs (Value)
        • 5.2.2.1. Anesthetics
        • 5.2.2.2. Pain killers
        • 5.2.2.3. Muscle relaxants
        • 5.2.2.4. Antidepressants
        • 5.2.2.5. Steroids
        • 5.2.2.6. Others
      • 5.2.3. Global Sciatica Treatment by: Non-Drug Treatment (Value)
        • 5.2.3.1. Physiotherapy
        • 5.2.3.2. Acupuncture
        • 5.2.3.3. Stimulation devices
        • 5.2.3.4. Surgery
        • 5.2.3.5. Others
      • 5.2.4. Global Sciatica Treatment by: Treatment (Value)
        • 5.2.4.1. Surgical Treatment
        • 5.2.4.2. Non-Surgical Treatment
      • 5.2.5. Global Sciatica Treatment by: End user (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Clinics
        • 5.2.5.3. Research & Academics
        • 5.2.5.4. Others
      • 5.2.6. Global Sciatica Treatment Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Sciatica Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Endo Pharmaceuticals Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. AstraZeneca (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novartis AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Johnson & Johnson Services, Inc.(United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Omega Laser Systems Ltd.(Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pfizer Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sanofi (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Sciatica Treatment Sale, by Type, Drugs, Non-Drug Treatment, Treatment, End user and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Sciatica Treatment (Value)
      • 7.2.1. Global Sciatica Treatment by: Type (Value)
        • 7.2.1.1. L4 Nerve Root Sciatica
        • 7.2.1.2. L5 Nerve Root Sciatica
        • 7.2.1.3. S1 Nerve Root Sciatica
        • 7.2.1.4. Others
      • 7.2.2. Global Sciatica Treatment by: Drugs (Value)
        • 7.2.2.1. Anesthetics
        • 7.2.2.2. Pain killers
        • 7.2.2.3. Muscle relaxants
        • 7.2.2.4. Antidepressants
        • 7.2.2.5. Steroids
        • 7.2.2.6. Others
      • 7.2.3. Global Sciatica Treatment by: Non-Drug Treatment (Value)
        • 7.2.3.1. Physiotherapy
        • 7.2.3.2. Acupuncture
        • 7.2.3.3. Stimulation devices
        • 7.2.3.4. Surgery
        • 7.2.3.5. Others
      • 7.2.4. Global Sciatica Treatment by: Treatment (Value)
        • 7.2.4.1. Surgical Treatment
        • 7.2.4.2. Non-Surgical Treatment
      • 7.2.5. Global Sciatica Treatment by: End user (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Clinics
        • 7.2.5.3. Research & Academics
        • 7.2.5.4. Others
      • 7.2.6. Global Sciatica Treatment Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Sciatica Treatment: by Type(USD Million)
  • Table 2. Sciatica Treatment L4 Nerve Root Sciatica , by Region USD Million (2013-2018)
  • Table 3. Sciatica Treatment L5 Nerve Root Sciatica , by Region USD Million (2013-2018)
  • Table 4. Sciatica Treatment S1 Nerve Root Sciatica , by Region USD Million (2013-2018)
  • Table 5. Sciatica Treatment Others , by Region USD Million (2013-2018)
  • Table 6. Sciatica Treatment: by Drugs(USD Million)
  • Table 7. Sciatica Treatment Anesthetics , by Region USD Million (2013-2018)
  • Table 8. Sciatica Treatment Pain killers , by Region USD Million (2013-2018)
  • Table 9. Sciatica Treatment Muscle relaxants , by Region USD Million (2013-2018)
  • Table 10. Sciatica Treatment Antidepressants , by Region USD Million (2013-2018)
  • Table 11. Sciatica Treatment Steroids , by Region USD Million (2013-2018)
  • Table 12. Sciatica Treatment Others , by Region USD Million (2013-2018)
  • Table 13. Sciatica Treatment: by Non-Drug Treatment(USD Million)
  • Table 14. Sciatica Treatment Physiotherapy , by Region USD Million (2013-2018)
  • Table 15. Sciatica Treatment Acupuncture , by Region USD Million (2013-2018)
  • Table 16. Sciatica Treatment Stimulation devices , by Region USD Million (2013-2018)
  • Table 17. Sciatica Treatment Surgery , by Region USD Million (2013-2018)
  • Table 18. Sciatica Treatment Others , by Region USD Million (2013-2018)
  • Table 19. Sciatica Treatment: by Treatment(USD Million)
  • Table 20. Sciatica Treatment Surgical Treatment , by Region USD Million (2013-2018)
  • Table 21. Sciatica Treatment Non-Surgical Treatment , by Region USD Million (2013-2018)
  • Table 22. Sciatica Treatment: by End user(USD Million)
  • Table 23. Sciatica Treatment Hospitals , by Region USD Million (2013-2018)
  • Table 24. Sciatica Treatment Clinics , by Region USD Million (2013-2018)
  • Table 25. Sciatica Treatment Research & Academics , by Region USD Million (2013-2018)
  • Table 26. Sciatica Treatment Others , by Region USD Million (2013-2018)
  • Table 27. South America Sciatica Treatment, by Country USD Million (2013-2018)
  • Table 28. South America Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 29. South America Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 30. South America Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 31. South America Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 32. South America Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 33. Brazil Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 34. Brazil Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 35. Brazil Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 36. Brazil Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 37. Brazil Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 38. Argentina Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 39. Argentina Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 40. Argentina Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 41. Argentina Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 42. Argentina Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 43. Rest of South America Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 44. Rest of South America Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 45. Rest of South America Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 46. Rest of South America Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 47. Rest of South America Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 48. Asia Pacific Sciatica Treatment, by Country USD Million (2013-2018)
  • Table 49. Asia Pacific Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 50. Asia Pacific Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 51. Asia Pacific Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 52. Asia Pacific Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 53. Asia Pacific Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 54. China Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 55. China Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 56. China Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 57. China Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 58. China Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 59. Japan Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 60. Japan Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 61. Japan Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 62. Japan Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 63. Japan Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 64. India Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 65. India Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 66. India Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 67. India Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 68. India Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 69. South Korea Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 70. South Korea Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 71. South Korea Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 72. South Korea Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 73. South Korea Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 74. Taiwan Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 75. Taiwan Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 76. Taiwan Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 77. Taiwan Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 78. Taiwan Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 79. Australia Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 80. Australia Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 81. Australia Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 82. Australia Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 83. Australia Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 84. Rest of Asia-Pacific Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 85. Rest of Asia-Pacific Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 86. Rest of Asia-Pacific Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 87. Rest of Asia-Pacific Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 88. Rest of Asia-Pacific Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 89. Europe Sciatica Treatment, by Country USD Million (2013-2018)
  • Table 90. Europe Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 91. Europe Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 92. Europe Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 93. Europe Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 94. Europe Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 95. Germany Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 96. Germany Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 97. Germany Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 98. Germany Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 99. Germany Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 100. France Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 101. France Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 102. France Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 103. France Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 104. France Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 105. Italy Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 106. Italy Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 107. Italy Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 108. Italy Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 109. Italy Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 110. United Kingdom Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 111. United Kingdom Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 112. United Kingdom Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 113. United Kingdom Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 114. United Kingdom Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 115. Netherlands Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 116. Netherlands Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 117. Netherlands Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 118. Netherlands Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 119. Netherlands Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 120. Rest of Europe Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 121. Rest of Europe Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 122. Rest of Europe Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 123. Rest of Europe Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 124. Rest of Europe Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 125. MEA Sciatica Treatment, by Country USD Million (2013-2018)
  • Table 126. MEA Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 127. MEA Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 128. MEA Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 129. MEA Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 130. MEA Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 131. Middle East Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 132. Middle East Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 133. Middle East Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 134. Middle East Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 135. Middle East Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 136. Africa Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 137. Africa Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 138. Africa Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 139. Africa Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 140. Africa Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 141. North America Sciatica Treatment, by Country USD Million (2013-2018)
  • Table 142. North America Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 143. North America Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 144. North America Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 145. North America Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 146. North America Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 147. United States Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 148. United States Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 149. United States Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 150. United States Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 151. United States Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 152. Canada Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 153. Canada Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 154. Canada Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 155. Canada Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 156. Canada Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 157. Mexico Sciatica Treatment, by Type USD Million (2013-2018)
  • Table 158. Mexico Sciatica Treatment, by Drugs USD Million (2013-2018)
  • Table 159. Mexico Sciatica Treatment, by Non-Drug Treatment USD Million (2013-2018)
  • Table 160. Mexico Sciatica Treatment, by Treatment USD Million (2013-2018)
  • Table 161. Mexico Sciatica Treatment, by End user USD Million (2013-2018)
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Sciatica Treatment: by Type(USD Million)
  • Table 171. Sciatica Treatment L4 Nerve Root Sciatica , by Region USD Million (2019-2024)
  • Table 172. Sciatica Treatment L5 Nerve Root Sciatica , by Region USD Million (2019-2024)
  • Table 173. Sciatica Treatment S1 Nerve Root Sciatica , by Region USD Million (2019-2024)
  • Table 174. Sciatica Treatment Others , by Region USD Million (2019-2024)
  • Table 175. Sciatica Treatment: by Drugs(USD Million)
  • Table 176. Sciatica Treatment Anesthetics , by Region USD Million (2019-2024)
  • Table 177. Sciatica Treatment Pain killers , by Region USD Million (2019-2024)
  • Table 178. Sciatica Treatment Muscle relaxants , by Region USD Million (2019-2024)
  • Table 179. Sciatica Treatment Antidepressants , by Region USD Million (2019-2024)
  • Table 180. Sciatica Treatment Steroids , by Region USD Million (2019-2024)
  • Table 181. Sciatica Treatment Others , by Region USD Million (2019-2024)
  • Table 182. Sciatica Treatment: by Non-Drug Treatment(USD Million)
  • Table 183. Sciatica Treatment Physiotherapy , by Region USD Million (2019-2024)
  • Table 184. Sciatica Treatment Acupuncture , by Region USD Million (2019-2024)
  • Table 185. Sciatica Treatment Stimulation devices , by Region USD Million (2019-2024)
  • Table 186. Sciatica Treatment Surgery , by Region USD Million (2019-2024)
  • Table 187. Sciatica Treatment Others , by Region USD Million (2019-2024)
  • Table 188. Sciatica Treatment: by Treatment(USD Million)
  • Table 189. Sciatica Treatment Surgical Treatment , by Region USD Million (2019-2024)
  • Table 190. Sciatica Treatment Non-Surgical Treatment , by Region USD Million (2019-2024)
  • Table 191. Sciatica Treatment: by End user(USD Million)
  • Table 192. Sciatica Treatment Hospitals , by Region USD Million (2019-2024)
  • Table 193. Sciatica Treatment Clinics , by Region USD Million (2019-2024)
  • Table 194. Sciatica Treatment Research & Academics , by Region USD Million (2019-2024)
  • Table 195. Sciatica Treatment Others , by Region USD Million (2019-2024)
  • Table 196. South America Sciatica Treatment, by Country USD Million (2019-2024)
  • Table 197. South America Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 198. South America Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 199. South America Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 200. South America Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 201. South America Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 202. Brazil Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 203. Brazil Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 204. Brazil Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 205. Brazil Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 206. Brazil Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 207. Argentina Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 208. Argentina Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 209. Argentina Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 210. Argentina Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 211. Argentina Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 212. Rest of South America Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 213. Rest of South America Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 214. Rest of South America Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 215. Rest of South America Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 216. Rest of South America Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 217. Asia Pacific Sciatica Treatment, by Country USD Million (2019-2024)
  • Table 218. Asia Pacific Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 219. Asia Pacific Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 220. Asia Pacific Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 221. Asia Pacific Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 222. Asia Pacific Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 223. China Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 224. China Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 225. China Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 226. China Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 227. China Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 228. Japan Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 229. Japan Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 230. Japan Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 231. Japan Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 232. Japan Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 233. India Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 234. India Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 235. India Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 236. India Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 237. India Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 238. South Korea Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 239. South Korea Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 240. South Korea Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 241. South Korea Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 242. South Korea Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 243. Taiwan Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 244. Taiwan Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 245. Taiwan Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 246. Taiwan Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 247. Taiwan Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 248. Australia Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 249. Australia Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 250. Australia Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 251. Australia Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 252. Australia Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 253. Rest of Asia-Pacific Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 254. Rest of Asia-Pacific Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 255. Rest of Asia-Pacific Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 256. Rest of Asia-Pacific Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 257. Rest of Asia-Pacific Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 258. Europe Sciatica Treatment, by Country USD Million (2019-2024)
  • Table 259. Europe Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 260. Europe Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 261. Europe Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 262. Europe Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 263. Europe Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 264. Germany Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 265. Germany Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 266. Germany Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 267. Germany Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 268. Germany Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 269. France Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 270. France Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 271. France Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 272. France Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 273. France Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 274. Italy Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 275. Italy Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 276. Italy Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 277. Italy Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 278. Italy Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 279. United Kingdom Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 280. United Kingdom Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 281. United Kingdom Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 282. United Kingdom Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 283. United Kingdom Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 284. Netherlands Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 285. Netherlands Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 286. Netherlands Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 287. Netherlands Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 288. Netherlands Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 289. Rest of Europe Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 290. Rest of Europe Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 291. Rest of Europe Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 292. Rest of Europe Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 293. Rest of Europe Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 294. MEA Sciatica Treatment, by Country USD Million (2019-2024)
  • Table 295. MEA Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 296. MEA Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 297. MEA Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 298. MEA Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 299. MEA Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 300. Middle East Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 301. Middle East Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 302. Middle East Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 303. Middle East Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 304. Middle East Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 305. Africa Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 306. Africa Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 307. Africa Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 308. Africa Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 309. Africa Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 310. North America Sciatica Treatment, by Country USD Million (2019-2024)
  • Table 311. North America Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 312. North America Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 313. North America Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 314. North America Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 315. North America Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 316. United States Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 317. United States Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 318. United States Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 319. United States Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 320. United States Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 321. Canada Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 322. Canada Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 323. Canada Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 324. Canada Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 325. Canada Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 326. Mexico Sciatica Treatment, by Type USD Million (2019-2024)
  • Table 327. Mexico Sciatica Treatment, by Drugs USD Million (2019-2024)
  • Table 328. Mexico Sciatica Treatment, by Non-Drug Treatment USD Million (2019-2024)
  • Table 329. Mexico Sciatica Treatment, by Treatment USD Million (2019-2024)
  • Table 330. Mexico Sciatica Treatment, by End user USD Million (2019-2024)
  • Table 331. Research Programs/Design for This Report
  • Table 332. Key Data Information from Secondary Sources
  • Table 333. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Sciatica Treatment: by Type USD Million (2013-2018)
  • Figure 5. Global Sciatica Treatment: by Drugs USD Million (2013-2018)
  • Figure 6. Global Sciatica Treatment: by Non-Drug Treatment USD Million (2013-2018)
  • Figure 7. Global Sciatica Treatment: by Treatment USD Million (2013-2018)
  • Figure 8. Global Sciatica Treatment: by End user USD Million (2013-2018)
  • Figure 9. South America Sciatica Treatment Share (%), by Country
  • Figure 10. Asia Pacific Sciatica Treatment Share (%), by Country
  • Figure 11. Europe Sciatica Treatment Share (%), by Country
  • Figure 12. MEA Sciatica Treatment Share (%), by Country
  • Figure 13. North America Sciatica Treatment Share (%), by Country
  • Figure 14. Global Sciatica Treatment share by Players 2018 (%)
  • Figure 15. Global Sciatica Treatment share by Players (Top 3) 2018(%)
  • Figure 16. Global Sciatica Treatment share by Players (Top 5) 2018(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Endo Pharmaceuticals Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Endo Pharmaceuticals Inc. (United States) Revenue: by Geography 2018
  • Figure 20. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. AstraZeneca (United Kingdom) Revenue: by Geography 2018
  • Figure 22. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Novartis AG (Switzerland) Revenue: by Geography 2018
  • Figure 24. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 25. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2018
  • Figure 26. Johnson & Johnson Services, Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 27. Johnson & Johnson Services, Inc.(United States) Revenue: by Geography 2018
  • Figure 28. Omega Laser Systems Ltd.(Netherlands) Revenue, Net Income and Gross profit
  • Figure 29. Omega Laser Systems Ltd.(Netherlands) Revenue: by Geography 2018
  • Figure 30. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Pfizer Inc. (United States) Revenue: by Geography 2018
  • Figure 32. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 33. Sanofi (France) Revenue: by Geography 2018
  • Figure 34. Global Sciatica Treatment: by Type USD Million (2019-2024)
  • Figure 35. Global Sciatica Treatment: by Drugs USD Million (2019-2024)
  • Figure 36. Global Sciatica Treatment: by Non-Drug Treatment USD Million (2019-2024)
  • Figure 37. Global Sciatica Treatment: by Treatment USD Million (2019-2024)
  • Figure 38. Global Sciatica Treatment: by End user USD Million (2019-2024)
  • Figure 39. South America Sciatica Treatment Share (%), by Country
  • Figure 40. Asia Pacific Sciatica Treatment Share (%), by Country
  • Figure 41. Europe Sciatica Treatment Share (%), by Country
  • Figure 42. MEA Sciatica Treatment Share (%), by Country
  • Figure 43. North America Sciatica Treatment Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Endo Pharmaceuticals Inc. (United States)
  • AstraZeneca (United Kingdom)
  • Novartis AG (Switzerland)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Johnson & Johnson Services, Inc.(United States)
  • Omega Laser Systems Ltd.(Netherlands)
  • Pfizer Inc. (United States)
  • Sanofi (France)
Additional players considered in the study are as follows:
Neurotech (United Kingdom) , Nidd Valley Medical Ltd.(United Kingdom) , Omron Healthcare, Inc. (United States) , Sollis Therapeutics (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation